This is consistent with our previous study in a cohort of 527 breast cancer patients which showed that high expression of cytoplasmic STAT3 was associated with reduced outcome while low expression of nuclear STAT3 was associated with poor outcomes [27]. Here, STAT3 is linked to breast cancer.